Does TACROLIMUS Cause Reversible cerebral vasoconstriction syndrome? 127 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 127 reports of Reversible cerebral vasoconstriction syndrome have been filed in association with TACROLIMUS (Tacrolimus). This represents 0.1% of all adverse event reports for TACROLIMUS.
127
Reports of Reversible cerebral vasoconstriction syndrome with TACROLIMUS
0.1%
of all TACROLIMUS reports
3
Deaths
64
Hospitalizations
How Dangerous Is Reversible cerebral vasoconstriction syndrome From TACROLIMUS?
Of the 127 reports, 3 (2.4%) resulted in death, 64 (50.4%) required hospitalization, and 19 (15.0%) were considered life-threatening.
Is Reversible cerebral vasoconstriction syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 127 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Reversible cerebral vasoconstriction syndrome?
ESCITALOPRAM OXALATE (165)
FLUOXETINE (154)
METHYLPREDNISOLONE (119)
SUMATRIPTAN (105)
VENLAFAXINE (105)
DULOXETINE (102)
SERTRALINE (102)
MYCOPHENOLATE MOFETIL (68)
CITALOPRAM HYDROBROMIDE (64)
PAROXETINE (60)
Which TACROLIMUS Alternatives Have Lower Reversible cerebral vasoconstriction syndrome Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB